Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
The Journal of Urology
|
May 25, 2018
The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass
Paras H Shah, Manaf A Alom, Bradley C Leibovich, et al.
The Journal of Urology
|
March 10, 2017
Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a
Paras H Shah, Daniel M Moreira, Vinay R Patel, et al.
BJU International
|
August 17, 2018
Implementation of multiparametric magnetic resonance imaging technology for evaluation of patients with suspicion for prostate cancer in the clinical practice setting
Paras H Shah, Vinay R Patel, Daniel M Moreira, et al.
Urology
|
June 17, 2025
Development and External Validation of a Local Pelvic Recurrence Risk Score After Radical Cystectomy: Identifying the Ideal Candidate for Adjuvant Radiation Clinical Trials
Matthew S Lee, Marco Moschini, Cameron J Britton, et al.
The Prostate
|
June 8, 2026
Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection Criteria
Eric V Li, Eman E Ahmed, Mohamed E Ahmed, et al.
World Journal of Urology
|
November 3, 2016
Active surveillance for incidental renal mass in the octogenarian
Kenan E Celtik, Paras H Shah, Vinay R Patel, et al.
Urology
|
November 13, 2018
Multi-institutional Evaluation of Producing and Testing a Novel 3D-Printed Laparoscopic Trainer
Egor Parkhomenko, Renai Yoon, Zhamshid Okhunov, et al.
The Journal of Urology
|
February 25, 2016
Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors
Paras H Shah, Daniel M Moreira, Zhamshid Okhunov, et al.
American Journal of Clinical Pathology
|
April 13, 2026
Sarcomatoid urothelial carcinoma with constitutive PD-L1 overexpression
Sounak Gupta, Farhad Kosari, Prabin Thapa, et al.
Nature Medicine
|
June 6, 2024
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
Roger Li, Paras H Shah, Tyler F Stewart, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
The Journal of Urology
|
May 25, 2018
The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass
Paras H Shah, Manaf A Alom, Bradley C Leibovich, et al.
The Journal of Urology
|
March 10, 2017
Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a
Paras H Shah, Daniel M Moreira, Vinay R Patel, et al.
BJU International
|
August 17, 2018
Implementation of multiparametric magnetic resonance imaging technology for evaluation of patients with suspicion for prostate cancer in the clinical practice setting
Paras H Shah, Vinay R Patel, Daniel M Moreira, et al.
Urology
|
June 17, 2025
Development and External Validation of a Local Pelvic Recurrence Risk Score After Radical Cystectomy: Identifying the Ideal Candidate for Adjuvant Radiation Clinical Trials
Matthew S Lee, Marco Moschini, Cameron J Britton, et al.
The Prostate
|
June 8, 2026
Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection Criteria
Eric V Li, Eman E Ahmed, Mohamed E Ahmed, et al.
World Journal of Urology
|
November 3, 2016
Active surveillance for incidental renal mass in the octogenarian
Kenan E Celtik, Paras H Shah, Vinay R Patel, et al.
Urology
|
November 13, 2018
Multi-institutional Evaluation of Producing and Testing a Novel 3D-Printed Laparoscopic Trainer
Egor Parkhomenko, Renai Yoon, Zhamshid Okhunov, et al.
The Journal of Urology
|
February 25, 2016
Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors
Paras H Shah, Daniel M Moreira, Zhamshid Okhunov, et al.
American Journal of Clinical Pathology
|
April 13, 2026
Sarcomatoid urothelial carcinoma with constitutive PD-L1 overexpression
Sounak Gupta, Farhad Kosari, Prabin Thapa, et al.
Nature Medicine
|
June 6, 2024
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
Roger Li, Paras H Shah, Tyler F Stewart, et al.
Page
of 5